AXSM R&D Expense Growth
Axsome Therapeutics Inc · R&D Expense Growth
AXSM R&D Expense Growth
Latest reported-2.03%period ending
AXSM FY R&D Growth (YoY) (0.00% → -2.03%)
Latest values, visible window
High-resolution chart · PNG
AXSM r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -2.0302% | |
| 91.004% | |
| 69.0234% | |
| -0.1963% | |
| -17.3445% | |
| 30.9383% | |
| 128.3334% | |
| 17.7248% | |
| -5.8597% | |
| 212.8213% | |
| 58.3704% | |
| 178.7289% | |
| 0% |